Julie M. Zito, PhD, a longtime member of the APHA Medical Care Section, a former chair of the Medical Care Section, and stalwart advocate for pharmacy policy, passed away on December 6, 2025. She was a good friend who always “liked” my Facebook posts on progressive issues. Along with Kathy Virgo, she guaranteed the quality… Read More »
Burnout among physicians and clinicians has reached alarming levels. Primary care, in particular, sits at the intersection of growing patient complexity, rising administrative burden, and relentless performance pressures tied to quality metrics and value-based care. Health systems increasingly look to team-based care as part of the solution, yet integration often happens without fully understanding how… Read More »
A recent JAMA article noted that only one-third of new drug approvals through the accelerated approval process by the FDA in the US or the conditional marketing authorization in the EU have shown therapeutic value. Many of these drugs are high cost, and this begs the question if we are spending our health care dollars appropriately. … Read More »
Despite a rapid expansion in the use of buprenorphine-naloxone (bup-nx) as a treatment for opioid use disorder, there is little understanding of the patterns of treatment. In a newly published-ahead-of-print Medical Care article, Brendan Saloner and colleagues from Johns Hopkins used an all-payer claims database to investigate what factors predict the duration of treatment, dosage, and continuity of treatment for… Read More »